Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase III Randomized, Open-Label Study of Optune Ttfields, 200KHZ Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
International Penile Advanced Cancer Trial International Rare Cancers Initiative study
Study Type: Treatment
Phase: III
NCTID: NCT02305654
Principal Investigator:
Elizabeth Wulff-Burchfield
Phase II Trial of Response Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors
Study Type: Treatment
Phase: II
NCTID: NCT01602666
Principal Investigator:
Advancing Treatment for Pediatric Craniopharyngioma: Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
Study Type: Other
Phase: N/A
NCTID: NCT03610906
Principal Investigator:
Kevin Ginn
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers ICONIC
Study Type: Treatment
Phase: II
NCTID: NCT03866382
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase 3 Randomized Study of Selumetinib versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 NF1 Associated Low-Grade Glioma LGG
Study Type: Treatment
Phase: III
NCTID: NCT03871257
Principal Investigator:
Keith August
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
Study Type: Treatment
Phase: II
NCTID: NCT04696029
Principal Investigator:
Kevin Ginn
A Phase III Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features
Study Type: Treatment
Phase: III
NCTID: NCT05382338
Principal Investigator:
Keith August
A Phase 2 Study of Dabrafenib NSC 763760 with Trametinib NSC 763093 after Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma HGG
Study Type: Treatment
Phase: II
NCTID: NCT03919071
Principal Investigator:
Keith August